Dr. Cheng-Di Chiu is a clinical-scientist and a neurosurgeon of China Medical University and University Hospital. His work mainly focuses on the biological mechanism participated in the formation/progression of hemorrhagic stroke by studying the key cell types and immunological factors which regulate the integrity of blood-brain barrier in early period of injury. He also investigates surgical and interventional approaches used to mitigate symptoms from disc degenerative disease. As a member of CMUH Spine Center, he recently designs and performs MSC-based therapy for sub-acute stage spinal cord injury, which was one of the leading protocol accepted by Taiwanese government and has been launched in CMUH since May 2021.   Cheng-Di Chiu, MD, PhD, MBA Department of Neurosurgery, China Medical University Hospital School of Medicine, China Medical University Spine Center, China Medical University Hospital Division of Minimal Invasive Spinal Neurosurgery, Department of Neurosurgery, China Medical University Hospital